Deborah Morena

464 total citations
11 papers, 351 citations indexed

About

Deborah Morena is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Deborah Morena has authored 11 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Deborah Morena's work include Chronic Lymphocytic Leukemia Research (4 papers), RNA modifications and cancer (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Deborah Morena is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), RNA modifications and cancer (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Deborah Morena collaborates with scholars based in Italy, United States and United Kingdom. Deborah Morena's co-authors include Riccardo Taulli, Valentina Foglizzo, Francesca Bersani, Ugo Ala, Carola Ponzetto, Gianpiero Pescarmona, Francesca Silvagno, Alessandro Morotti, Chiara Riganti and Federica Di Nicolantonio and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Deborah Morena

11 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Morena Italy 8 222 92 75 65 56 11 351
Vincent Roh Switzerland 11 231 1.0× 104 1.1× 147 2.0× 45 0.7× 38 0.7× 15 424
Julian Musa Germany 8 334 1.5× 136 1.5× 113 1.5× 108 1.7× 39 0.7× 18 500
Chongwei Ke China 11 152 0.7× 61 0.7× 94 1.3× 98 1.5× 29 0.5× 31 342
Terry J. Shackleford United States 6 220 1.0× 64 0.7× 114 1.5× 48 0.7× 20 0.4× 11 320
Georgina Mancinelli United States 9 131 0.6× 68 0.7× 155 2.1× 24 0.4× 28 0.5× 13 316
Thanemozhi G. Natarajan United States 11 280 1.3× 103 1.1× 97 1.3× 106 1.6× 55 1.0× 19 401
Marsha D. Wallace United Kingdom 9 274 1.2× 97 1.1× 97 1.3× 35 0.5× 31 0.6× 15 432
Miho Harada Japan 11 167 0.8× 102 1.1× 87 1.2× 50 0.8× 57 1.0× 27 368
Shi‐He Liu United States 14 219 1.0× 77 0.8× 116 1.5× 21 0.3× 29 0.5× 26 394
Baocheng Gong China 10 140 0.6× 72 0.8× 77 1.0× 95 1.5× 31 0.6× 30 310

Countries citing papers authored by Deborah Morena

Since Specialization
Citations

This map shows the geographic impact of Deborah Morena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Morena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Morena more than expected).

Fields of papers citing papers by Deborah Morena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Morena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Morena. The network helps show where Deborah Morena may publish in the future.

Co-authorship network of co-authors of Deborah Morena

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Morena. A scholar is included among the top collaborators of Deborah Morena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Morena. Deborah Morena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bersani, Francesca, Deborah Morena, Alessandro Morotti, et al.. (2020). Future perspectives from lung cancer pre-clinical models: new treatments are coming?. Translational Lung Cancer Research. 9(6). 2629–2644. 7 indexed citations
2.
Godel, Martina, Deborah Morena, Ilaria Buondonno, et al.. (2020). Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma. International Journal of Molecular Sciences. 21(12). 4500–4500. 63 indexed citations
3.
Carrà, Giovanna, Cristina Panuzzo, Deborah Morena, et al.. (2017). BET Inhibitors in Chronic Lymphocytic Leukemia: JQ1 Synergizes with Venetoclax in Promoting Apoptosis. Blood. 130. 2542. 3 indexed citations
4.
Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations
5.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2017). Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. Oncotarget. 8(22). 35508–35522. 59 indexed citations
6.
Bersani, Francesca, Deborah Morena, Valentina Foglizzo, et al.. (2016). Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma. Cancer Research. 76(20). 6095–6106. 31 indexed citations
7.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2016). Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16. S49–S50. 1 indexed citations
8.
Carrà, Giovanna, Cristina Panuzzo, Sabrina Crivellaro, et al.. (2016). The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia. Oncology Letters. 12(5). 3123–3126. 5 indexed citations
9.
Morena, Deborah, Valentina Foglizzo, Francesca Bersani, et al.. (2015). SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma. Cell Cycle. 14(9). 1389–1402. 42 indexed citations
10.
11.
Taulli, Riccardo, Valentina Foglizzo, Deborah Morena, et al.. (2013). Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. Oncogene. 33(18). 2354–2362. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Roh Breakdown of academic impact, for papers by Julian Musa Breakdown of academic impact, for papers by Chongwei Ke Breakdown of academic impact, for papers by Terry J. Shackleford Breakdown of academic impact, for papers by Georgina Mancinelli Breakdown of academic impact, for papers by Thanemozhi G. Natarajan Breakdown of academic impact, for papers by Marsha D. Wallace Breakdown of academic impact, for papers by Miho Harada Breakdown of academic impact, for papers by Shi‐He Liu Breakdown of academic impact, for papers by Baocheng Gong
Rankless by CCL
2026